• Jazz Pharmaceuticals (NASDAQ:JAZZ) Receives "Overweight" Rating from Piper Sandler

    Источник: Buzz FX / 27 фев 2025 13:46:20   America/New_York


    Jazz Pharmaceuticals (NASDAQ:JAZZ) Receives "Overweight" Rating from Piper Sandler Written by MarketBeat February 27, 2025 Share Link copied to clipboard. Jazz Pharmaceuticals ( NASDAQ:JAZZ - Get Free Report ) 's stock had its "overweight"
    Read more...
Опубликовать